SERENADE: No Benefit, Possible Harm With Macitentan in HFpEF and PAH

In what might prove the swan song for ERAs in HF, SERENADE tried to exclude patients with fluid retention—to no avail.

Related Keywords

Northwestern University ,Illinois ,United States ,Netherlands ,Groningen ,Madrid ,Spain ,California ,Chicago ,San Francisco ,Adriaan Voors ,Sanjiv Shah ,John Teerlink ,University Of California ,Md Northwestern University ,Md San Francisco Va Medical Center ,Phd University Of Groningen ,European Society Of Cardiology Heart Failure Congress ,European Society ,Cardiology Heart Failure Congress ,